AAAAAA

   
Results: 1-10 |
Results: 10
Spherical plant viruses: interactions in solution, phase diagrams and crystallization of brome mosaic virus
Authors: Casselyn, M Perez, J Tardieu, A Vachette, P Witz, J Delacroix, H
Citation: M. Casselyn et al., Spherical plant viruses: interactions in solution, phase diagrams and crystallization of brome mosaic virus, ACT CRYST D, 57, 2001, pp. 1799-1812
Lens crystallins and oxidation: the special case of gamma S
Authors: Skouri-Panet, F Bonnete, F Prat, K Bateman, OA Lubsen, NH Tardieu, A
Citation: F. Skouri-panet et al., Lens crystallins and oxidation: the special case of gamma S, BIOPHYS CH, 89(1), 2001, pp. 65-76
Structure of the macromolecular solutions that generate crystals
Authors: Tardieu, A Finet, S Bonnete, F
Citation: A. Tardieu et al., Structure of the macromolecular solutions that generate crystals, J CRYST GR, 232(1-4), 2001, pp. 1-9
alpha-crystallin interaction forces studied by small angle X-ray scattering and numerical simulations
Authors: Finet, S Tardieu, A
Citation: S. Finet et A. Tardieu, alpha-crystallin interaction forces studied by small angle X-ray scattering and numerical simulations, J CRYST GR, 232(1-4), 2001, pp. 40-49
Influence of the growth parameters on the electrical properties of thin polycrystalline CVD diamond films
Authors: Jany, C Tardieu, A Gicquel, A Bergonzo, P Foulon, F
Citation: C. Jany et al., Influence of the growth parameters on the electrical properties of thin polycrystalline CVD diamond films, DIAM RELAT, 9(3-6), 2000, pp. 1086-1090
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome)
Authors: Guerrero, RAA Amuchastegui, M Badaracco, J Elizari, M Martellotto, R De la Hoz, RP Ramos, JL Salvati, AM Sinisi, A Torre, H Aroney, G Campbell, T Garrahy, P",Lalman,"Liebens, I Renard, M Bastecky, J Bocek, P Cepelak, V Dvorak, K Gregor, J Janousek, S Jansky, P Jirmar, R Kamenik, L Rybka, J Spacek, R Spinar, J Svitil, P Zeman, K Alagha, Z Allam, S Barnay, C Baudouy, M Beltran, J Berland, J Berthou, JD Bery, E Bessede, G Beygui, F Bickert, P Boshat, J Boulenc, JM Bourlard, P Bouthillier, D Brandt, C Cattan, S Charbonnier, B Citron, B Coisne, D Coupillaud, J Da Costa, A Dambrine, P Danchin, N Delarche, N Dequeker, JL Desjouaux, E Dievart, F Dujardin, JJ Durand, P Fadel, N Fichter, P Galinier, M Gryman, R Gauthier, J Geslin, P Godard, S Grollier, G Guerot, C Gully, C Janin-Manificat, L Joly, P Joseph, T Juillard, A Ketelers, JY Lagorce, P Laine, E Lang, M Lanney-Courten, JE Le Helloco, A Ledru, F Levy, S Litvine-Itaya, L Lopez, M Mansour, M Mathurin, C Meyer, G Mossaz, R Nedelec, G Ollitrault, J Pacouret, G Perchet, H Poitrineau, O Richard, M Rocher, R Rougier, L Sagnol, P Tardieu, A Thery, C Thieuleux, F Touboul, P Tran-Tanh, X Veyrat, A Villarem, D Werquin, S Skoufas, P Fotiadis, I Xenodochidis, C Karidis, K Limberi, S Papasteriadis, E Giokas, K Kremastinos, D Polichronaki, E Moshos, N Daskalakis, I Janecsko, M Janosi, A Kalo, E Karpati, P Mezofi, M Nyaradi, A Ofner, P Oze, B Poor, F Preda, I Ronaszeki, A Valyi, P Zamolyi, K Davini, P Martines, C Melandri, F Pasotti, C Pettinati, G Veze, I Kochkarev, F Erpelding, J Halaczkiewicz, H Ilmuzynska, K Kurowski, M Lasota-Czopnik, A Markiewicz, M Musial, W Nartowicz, E Pasyk, S Prastowski, W Ruszkowski, J Sadowski, Z Sas, M Stopinski, M Ujda, M Wojciechowski, D Diniz, M Drumond, A Rodrigues, P Pereira, MA Correia, A Scherbak, A Irklienko, K Dudko, L Goloschekin, B Maximova, G Sorokin, L Inyushin, A Bzhelianskaia, V Kostenko, V Stefanenko, M Bilich, A Froufe, G Masip, J Pajaron, A Roura, J Sanz, G Valle, V Caduff, B Moccetti, T Noseda, G Simonin, C Baars, HF Bernink, PJLM Daniels, MCG Gobel, E Nagelsmit, MJ Ramdat, AR Senden, PJ van Rossum, P van Wijk, LM Withagen, AJAM Crowe, PF Davidson, C Handler, CE",McNeil,"Molajo, AO
Citation: Raa. Guerrero et al., Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome), EUR HEART J, 20(21), 1999, pp. 1553-1562
Protein interactions in concentrated ribonuclease solutions
Authors: Boyer, M Roy, MO Jullien, M Bonnete, F Tardieu, A
Citation: M. Boyer et al., Protein interactions in concentrated ribonuclease solutions, J CRYST GR, 196(2-4), 1999, pp. 185-192
Proteins in solution: from X-ray scattering intensities to interaction potentials
Authors: Tardieu, A Le Verge, A Malfois, M Bonnete, F Finet, S Ries-Kautt, M Belloni, L
Citation: A. Tardieu et al., Proteins in solution: from X-ray scattering intensities to interaction potentials, J CRYST GR, 196(2-4), 1999, pp. 193-203
Interactions in solution of a large oligomeric protein
Authors: Budayova, M Bonnete, F Tardieu, A Vachette, P
Citation: M. Budayova et al., Interactions in solution of a large oligomeric protein, J CRYST GR, 196(2-4), 1999, pp. 210-219
Second virial coefficient: variations with lysozyme crystallization conditions
Authors: Bonnete, F Finet, S Tardieu, A
Citation: F. Bonnete et al., Second virial coefficient: variations with lysozyme crystallization conditions, J CRYST GR, 196(2-4), 1999, pp. 403-414
Risultati: 1-10 |